An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer
| Image |  |
|---|---|
| Description | scientific article published in January 2009 |
| Author/s |
author: Bent Ejlertsen |
| Publication date | January 1, 2009 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |